Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Abstracts

Abstracts

  • Tuesday, October 1, 2024
  • 8:00 AM - 8:10 AM ET
    257 - Risk Factors Correlated with Brain Metastases Risk in Limited-Stage Small Cell Lung Cancer
    Location: Room 147
    Presenter: Li Li, MD, PhD, RT – Shandong Cancer Hospital and Institute
  • 8:10 AM - 8:20 AM ET
    258 - Exploratory Analysis of Plasma Protein Abundance Kinetics from I-SABR, A Randomized Phase II Trial of Stereotactic Ablative Radiotherapy with or without Nivolumab in Stage I-IIA or Recurrent Non-Small
    Location: Room 147
    Presenter: Aaron Seo, MD, PhD – MD Anderson Cancer Center
  • 8:20 AM - 8:30 AM ET
    259 - Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer
    Location: Room 147
    Presenter: Benjamin Lok, MD – Princess Margaret Cancer Centre
  • 8:30 AM - 8:40 AM ET
    260 - Consolidative Stereotactic Radiotherapy in Metastatic EGFR-Mutant Non-Small Cell Lung Cancer Receiving First-Line Third-Generation EGFR Tyrosine Kinase Inhibitors: A Prospective Phase II Trial
    Location: Room 147
    Presenter: Yue Zhou, MD – Fudan University
  • 8:40 AM - 8:50 AM ET
    261 - A Phase II Trial of Stereotactic Body Radiotherapy (SBRT) in Patients with Stage IV Oncogene-Driven Non-Small Cell Lung Cancer (NSCLC)
    Location: Room 147
    Presenter: Florence Keane, MD – Massachusetts General Hospital
  • 8:50 AM - 9:00 AM ET
    262 - External Validation of Oligometastatic Genomic Signature in Non-Small Cell Lung Cancer Patients
    Location: Room 147
    Presenter: Ariel Choi, MD – Wake Forest Baptist Medical Center
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 158
  • 8:05 AM - 8:10 AM ET
    1042 - Radiation Oncologist Workload after Traditional Office Hours: A Threat to Work-Life Balance?
    Location: Room 158
    Presenter: Marc Gaudet, MD – The Ottawa Hospital, University of Ottawa
  • 8:10 AM - 8:15 AM ET
    1043 - Department Wellbeing is Improved after a Process Improvement on Call Workflow Optimization
    Location: Room 158
    Presenter: Claire Baniel, MD – Stanford University
  • 8:15 AM - 8:20 AM ET
    1044 - TEAMRO: Final Analysis of TEAMRO (TEAching Mentorship in Radiation Oncology), A Multicenter Prospective Phase 2 Intervention Study on Teaching Mentorship Skills to Resident Physicians Working with Med
    Location: Room 158
    Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber
  • 8:20 AM - 8:25 AM ET
    1045 - Patterns of Contouring Mistakes in the Novice Resident: A Qualitative Analysis to Guide Future Educational Efforts
    Location: Room 158
    Presenter: Megan Orr, MD – UC San Diego Health
  • 8:25 AM - 8:30 AM ET
    1046 - AI Auto Contouring and Its Impact on Resident Education
    Location: Room 158
    Presenter: Alexander Qian, MD – University of California San Francisco
  • 8:30 AM - 8:35 AM ET
    1047 - Optimizing Leadership Development Strategies for Enhanced Leader and Team Impact
    Location: Room 158
    Presenter: Amanda Woods, PhD – The University of Texas MD Anderson Cancer Center
  • 8:35 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 158
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 158
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 140
  • 8:05 AM - 8:10 AM ET
    1037 - ctDNA Predicts Pain Response in a Multi-Institutional Phase II Trial of Palliative Radiation, Palbociclib and Hormone Therapy in Metastatic Breast Cancer
    Location: Room 140
    Presenter: Mylin Torres, MD, FASTRO – Emory University
  • 8:10 AM - 8:15 AM ET
    1036 - Phase 2 Trial of Stereotactic MR-Guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
    Location: Room 140
    Presenter: Michael Chuong, MD – Miami Cancer Institute
  • 8:15 AM - 8:20 AM ET
    1038 - Final Report of a Phase I/II Study of BMS-986156 (Glucocorticoid-Induced TNFR-Related Gene [GITR] Agonist) with Ipilimumab or Nivolumab with/without Stereotactic Ablative Radiotherapy in Patients with
    Location: Room 140
    Presenter: Xinyan Xu, MD – MD Anderson Cancer Center
  • 8:20 AM - 8:25 AM ET
    1039 - Identifying Patients with Bone Metastases at Highest Risk of Skeletal-Related Events and Understanding Underuse of Bone Modifying Agents: A Retrospective Analysis
    Location: Room 140
    Presenter: Lakshmi Rekha Narra, MD – Rutgers Cancer Institute of New Jersey
  • 8:25 AM - 8:30 AM ET
    1040 - Development of Nomograms to Predict Polymetastatic Progression Free Survival and Overall Survival in Patients Treated with Stereotactic Ablative Radiotherapy for Oligometastatic or Oligoprogressive Ca
    Location: Room 140
    Presenter: Subhadip Das, MD – BC Cancer Surrey and University of British Columbia
  • 8:30 AM - 8:35 AM ET
    1041 - Progress in Shortening Treatment Courses for Bone Metastases in a Statewide Quality Consortium
    Location: Room 140
    Presenter: Luke Higgins, MD – University of Michigan
  • 8:35 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 140
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 140
  • 8:00 AM - 8:05 AM ET
    Introduction
    Location: Room 152
  • 8:05 AM - 8:10 AM ET
    1030 - Hypoxia Detection in Prostate Cancer with Oxygen-Enhanced BOLD MRI
    Location: Room 152
    Presenter: Martin Swinton, MBBChir – The Christie NHS Foundation Trust
  • 8:10 AM - 8:15 AM ET
    1031 - Using Virtual Monoenergetic Images and Electron Density (Rho) Images from Photon-Counting CT (PCCT) for Radiation Therapy (RT) Dose Calculation: A Comparison Study
    Location: Room 152
    Presenter: Xin Wu, MS – Duke University Medical Center
  • 8:15 AM - 8:20 AM ET
    1032 - Comparison of Enhanced Cone-Beam CT Using Next Generation Reconstruction with Deep Learning-Based Synthetic CT for Adaptive Radiotherapy in Pelvic Cancers
    Location: Room 152
    Presenter: Eenas Omari, PhD, DABR – Medical College of Wisconsin
  • 8:20 AM - 8:25 AM ET
    1033 - A Clinical Evaluation of Spiral 4DCT and Intelligent 4DCT Sequence Scanning
    Location: Room 152
    Presenter: Yao Hao, PhD – Washington University in St. Louis
  • 8:25 AM - 8:30 AM ET
    1034 - Impact of Synthetic PET Evaluation prior to PET-Guided Functional Modeling in Optimizing Patient Selection for Biology-Guided Radiotherapy
    Location: Room 152
    Presenter: Daniel Hicks, MD – Yale New Haven Hospital
  • 8:30 AM - 8:35 AM ET
    1035 - Precision Radiotherapy for Hepatocellular Carcinoma: Exploring the Clinical Utility of Functional Liver Avoidance Planning
    Location: Room 152
    Presenter: Afua Yorke, PhD – University of Washington
  • 8:35 AM - 8:55 AM ET
    Questions and Answers
    Location: Room 152
  • 8:55 AM - 9:00 AM ET
    Closing
    Location: Room 152
  • 12:45 PM - 12:50 PM ET
    Introduction
    Location: Room 144
  • 12:50 PM - 12:55 PM ET
    1064 - Beyond Involved-Site Radiotherapy: NRG, COG, Alliance, ECOG-ACRIN, SWOG and CCTG Consensus Nomenclature for Radiation Targets on NCTN Lymphoma Trials
    Location: Room 144
    Presenter: Bradford Hoppe, MD, FASTRO, MPH – Mayo Clinic Florida
  • 12:55 PM - 1:00 PM ET
    1060 - The Effect of Palliative Radiotherapy Field Volume on Rates of Significant Hematologic Toxicity in Patients with Multiple Myeloma
    Location: Room 144
    Presenter: Samuel Zhang, MD – Cedars-Sinai Medical Center
  • 1:00 PM - 1:05 PM ET
    1061 - Optimizing Low Dose Radiotherapy for Indolent Lymphomas: Comparing 4 Gy x 2 vs. 2 Gy x 2
    Location: Room 144
    Presenter: Jessica Burlile, MD – Mayo Clinic College of Medicine and Science Rochester
  • 1:05 PM - 1:10 PM ET
    1059 - Detection of Early Cardiotoxicity after Anthracyclines and Mediastinal Radiotherapy Using Cardiac PET/MRI
    Location: Room 144
    Presenter: Georgios Ntentas, DPhil – Guy's and St Thomas' NHS Foundation Trust
  • 1:10 PM - 1:15 PM ET
    1062 - Radiation-Related Late Toxicities Following Total Marrow Irradiation Transplant Conditioning Regimens
    Location: Room 144
    Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center
  • 1:15 PM - 1:20 PM ET
    1063 - Radiate Equity: The Inclusion of Radiation Oncology and Other Specialities in Lymphoma Collaborative Groups
    Location: Room 144
    Presenter: Omran Saifi, MD – Mayo Clinic Florida
  • 1:20 PM - 1:40 PM ET
    Questions and Answers
    Location: Room 144
  • 1:40 PM - 1:45 PM ET
    Closing
    Location: Room 144
  • 12:45 PM - 12:50 PM ET
    Introduction
    Location: Room 140
  • 12:50 PM - 12:55 PM ET
    1054 - Prospective Four Year Single Institution Outcomes of 1.5 Tesla MR Linac Based Radiotherapy from the MOMENTUM Study
    Location: Room 140
    Presenter: Aronne Schottstaedt, MD, MS – MCWAH
  • 12:55 PM - 1:00 PM ET
    1055 - Prostate Cancer Survivors Long-Term Supportive Care Needs: Results from a Population-Based Cohort
    Location: Room 140
    Presenter: Yahui Xie, BA – University of Kansas Cancer Center
  • 1:00 PM - 1:05 PM ET
    1056 - Association between NCCN Distress Thermometer Screening Data and Natural Language Processing-Identified Toxicities during Radiotherapy
    Location: Room 140
    Presenter: Michelle Zhao, BA – UCSF
  • 1:05 PM - 1:10 PM ET
    1057 - Early Detection of Radiation-Induced Cardiotoxicity in Patients Receiving Thoracic Radiation
    Location: Room 140
    Presenter: Steven Montalvo, MD – UT Southwestern Medical Center
  • 1:15 PM - 1:40 PM ET
    Questions and Answers
    Location: Room 140
  • 1:35 PM - 1:45 PM ET
    1058 - Quality of Life after Ablative 5-Fraction Radiation Therapy from the Phase 2 SMART Pancreas Trial
    Location: Room 140
    Presenter: Michael Chuong, MD – Miami Cancer Institute
  • 1:40 PM - 1:45 PM ET
    Closing
    Location: Room 140
  • 12:45 PM - 12:55 PM ET
    277 - The Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events Following Modern Breast Radiotherapy
    Location: Room 207
    Presenter: Michael Roumeliotis, PhD – Johns Hopkins University
  • 12:55 PM - 1:05 PM ET
    278 - A Virtual Program for Fatigue among Women Undergoing Radiation Treatment: Results from a Randomized Controlled Basket Trial
    Location: Room 207
    Presenter: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center
  • 1:05 PM - 1:15 PM ET
    279 - Safety and Efficacy of Combined Trastuzumab-Deruxtecan and Concurrent Radiation Therapy in Breast Cancer: The TENDANCE Multicentric French Study (Trastuzumab-Deruxtecan and Concurrent Radiation Therap
    Location: Room 207
    Presenter: Kamel Debbi, MD – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII
  • 1:15 PM - 1:25 PM ET
    280 - Characterization of Skin Microbiome Profile before and during Radiation Therapy and Its Correlation to the Occurrence and Severity of Radiation Dermatitis
    Location: Room 207
    Presenter: Roxolyana Abdah-Bortnyak, MD – Rambam Health Care Campus
  • 1:25 PM - 1:35 PM ET
    281 - A Phase I/II Trial of Spectrophotometric Skin Changes during and after Radiotherapy and Correlation with Radiation-Induced Skin Toxicity in Breast Cancer Patients with Skin of Color
    Location: Room 207
    Presenter: Juhi Purswani, MD – New York University School of Medicine
  • 1:35 PM - 1:45 PM ET
    282 - Analysis of Rib Fracture Risk after Breast Radiation with Various Dose Fractionations
    Location: Room 207
    Presenter: Jackson Howell, MD – University of Utah Huntsman Cancer Institute
  • 1:45 PM - 1:55 PM ET
    Discussant
    Location: Room 207
    Discussant: Youlia Kirova, MD – Institut Curie
  • 12:45 PM - 12:55 PM ET
    283 - Measuring the Integration of Stereotactic Ablative Radiotherapy plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes
    Location: Room 147
    Presenter: Vivian Tan, MD – London Health Sciences Centre
  • 12:55 PM - 1:05 PM ET
    284 - A Phase II Randomized Trial of Radical Resection vs. Stereotactic Body Radiation Therapy (SBRT) in Patients with Operable Stage I Non-Small Cell Lung Cancer (NSCLC): Final Report Of RTOG-F3502
    Location: Room 147
    Presenter: Feng-Ming Kong, MD, PhD, FASTRO, FACR – University of Hong Kong
  • 1:05 PM - 1:15 PM ET
    285 - A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
    Location: Room 147
    Presenter: Mark Farrugia, MD, PhD – Roswell Park Cancer Institute
  • 1:15 PM - 1:25 PM ET
    286 - Dosimetric Outcomes of SBRT to Ultracentral Lung Tumors: Lessons from the SUNSET Trial
    Location: Room 147
    Presenter: Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network
  • 1:25 PM - 1:35 PM ET
    287 - Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: Final Results from a Nonrandomized Contr
    Location: Room 147
    Presenter: Percy Lee, MD, FASTRO – City of Hope National Medical Center
  • 1:35 PM - 1:45 PM ET
    288 - A Phase I Study of Cyclical Hypofractionated Palliative Radiation (Quad Shot) for Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial
    Location: Room 147
    Presenter: Helen Zhang, MD – Memorial Sloan Kettering Cancer Center
  • 1:45 PM - 1:55 PM ET
    Discussant
    Location: Room 147
    Discussant: Clifford Robinson, MD, FASTRO – Washington University School of Medicine in St. Louis
  • 12:45 PM - 12:55 PM ET
    263 - The Eclipse-Radiotherapy Combined with ICI Orchestrates CD8+ T Cell- and NK Cell-Dependent Anti-Tumor Efficacy against Bulky Tumors
    Location: Room 150
    Presenter: Ren Luo, MD, PhD – West China Hospital of Sichuan University
  • 12:55 PM - 1:05 PM ET
    264 - Tumor Immunity Following Radiopharmaceutical + Checkpoint Blockade Varies with Treatment Sequence, Radioisotope and Tumor Immunogenicity
    Location: Room 150
    Presenter: Caroline Kerr, PhD – University of Wisconsin-Madison
  • 1:05 PM - 1:15 PM ET
    265 - Combining Proton Radiation Therapy and Mesothelin-Targeting Chimeric Antigen Receptor T-cell Therapy to Improve Outcomes in Pancreatic Cancer
    Location: Room 150
    Presenter: Uri Amit, MD, PhD, MPH – Tel Aviv Sourasky Medical Center- Ichilov Hospital
  • 1:15 PM - 1:25 PM ET
    266 - A Microbial-Inspired Antibody-Drug Conjugate Unleashes Macrophage Functionalities for Cancer Immunotherapy
    Location: Room 150
    Presenter: Benjamin Schrank, MD, PhD – MD Anderson Cancer Center
  • 1:25 PM - 1:35 PM ET
    267 - Tilting Immunometabolic Balance of Tumor Microenvironment by Targeting ENO1 in KRAS-Mutated Colorectal and Pancreatic Cancers
    Location: Room 150
    Presenter: K. S. Clifford Chao, MD – China Medical University Hospital
  • 1:35 PM - 1:45 PM ET
    268 - The Role of RIPK1 in Mediating Enhanced Immune Responses Following Radiotherapy
    Location: Room 150
    Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
  • 1:45 PM - 1:55 PM ET
    269 - Radiation-Induced TREM2-Expression on Tumor-Associated Macrophages Is a Target for Modulation of Immune Responses in Prostate Cancer
    Location: Room 150
    Presenter: Janny Villa-Pulgarin, PhD – Weill Cornell Medical College
  • 12:45 PM - 12:55 PM ET
    270 - Quantitative DW-MRI Monitoring of Metastatic Lymph Nodes in HPV+ Head and Neck Cancer Using MR-Linac
    Location: Room 152
    Presenter: Dina El-Habashy, MD, MS – Corewell Health William Beaumont University Hospital
  • 12:55 PM - 1:05 PM ET
    271 - Assessing Multi-Modality Imaging of Radiation Damage to Bone Marrow through Rigid Registration and Deformable Image Registration
    Location: Room 152
    Presenter: Carolyn Eckrich, MS, BS – University of Wisconsin
  • 1:05 PM - 1:15 PM ET
    272 - Impact of Organ-at-Risk (OAR) Radiation Dosimetry on Acute and Late Toxicity after Prostate Stereotactic Body Radiation Therapy (SBRT): A Post-Hoc Analysis of a Phase III Randomized Clinical Trial of
    Location: Room 152
    Presenter: Beth Neilsen, MD, PhD – University of California Los Angeles
  • 1:15 PM - 1:25 PM ET
    273 - Redefining Breast Cancer Tumor Size Classification through Big Data Analytics: A New Approach to Enhancing Prognostic Accuracy and Personalized Treatment
    Location: Room 152
    Presenter: Bin Feng, MS, BS – Chongqing University Cancer Hospital
  • 1:25 PM - 1:35 PM ET
    274 - Evaluation of Immune System Plasticity with a Multi-Compartment Model of Immuno-Positron Emission Tomography
    Location: Room 152
    Presenter: William Watkins, PhD – City of Hope National Medical Center
  • 1:35 PM - 1:45 PM ET
    275 - Patterns of Response in HNSCC Subregions Using Daily Quantitative MRI from MR-Guided Radiation Therapy
    Location: Room 152
    Presenter: Ryan Bonate, BS – Medical College of Wisconsin
  • 1:45 PM - 1:55 PM ET
    276 - Radiogenomic Deep Ensemble Learning for Identifying Radionecrosis Following Brain Metastasis Stereotactic Radiosurgery (SRS)
    Location: Room 152
    Presenter: Jingtong Zhao, MS, BS – Duke University
  • 2:30 PM - 2:35 PM ET
    Introduction
    Location: Room 140
  • 2:35 PM - 2:40 PM ET
    1048 - Bridging Prediction and Causality: Deciphering Clinical Outcomes in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation via Multitask Machine Learning and Causal Inference of Proto
    Location: Room 140
    Presenter: Sang Ho Lee, PhD – University of Pennsylvania
  • 2:40 PM - 2:45 PM ET
    1049 - Deep Learning Based Facial Age Phenotyping in a Large-Scale, Real-World Cancer Patient Population
    Location: Room 140
    Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
  • 2:45 PM - 2:50 PM ET
    1050 - Predicting Acute Care Visits during Radiation Therapy with Machine Learning and Natural Language Processing
    Location: Room 140
    Presenter: Sarah Hampson, MD – University of California San Francisco
  • 2:50 PM - 2:55 PM ET
    1051 - Pulmonary Vessel Dosimetry and Morphological Re-Modeling after Thoracic Radiation Therapy
    Location: Room 140
    Presenter: Christian Guthier, PhD, MS – Brigham and Womens Hospital
  • 2:55 PM - 3:00 PM ET
    1052 - Predicting Pulmonary Toxicity in Lung Cancer Patients with Interstitial Lung Disease Receiving SABR Using Machine Learning: A Secondary Analysis of ASPIRE-ILD
    Location: Room 140
    Presenter: Matthew Gil, MSc – National Health Service
  • 3:00 PM - 3:10 PM ET
    Discussant
    Location: Room 140
    Discussant: Andrew Hope, MD – Princess Margaret Cancer Center / University of Toronto
  • 3:10 PM - 3:25 PM ET
    Questions and Answers
    Location: Room 140
  • 3:25 PM - 3:30 PM ET
    Closing
    Location: Room 140
  • 2:30 PM - 2:35 PM ET
    Introduction
    Location: Room 151
  • 2:35 PM - 2:40 PM ET
    1066 - Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era
    Location: Room 151
    Presenter: Andrew Arifin, MD – London Health Sciences Centre
  • 2:40 PM - 2:45 PM ET
    1067 - Evaluation of Genomic and Pathologic Features Associated with Outcomes among Patients with Sentinel Lymph Node-Positive Melanoma in the Contemporary Era
    Location: Room 151
    Presenter: Stephanie Dudzinski, MD, PhD – MD Anderson Cancer Center
  • 2:45 PM - 2:50 PM ET
    1068 - Hypofractionated Radiation Therapy for Unresectable or Bulky Metastatic Melanoma
    Location: Room 151
    Presenter: Devarati Mitra, MD, PhD – MD Anderson Cancer Center
  • 2:50 PM - 2:55 PM ET
    1069 - Preoperative Hypofractionated Radiotherapy with Locoregional Hyperthermia in Recurrent and Radiation-Associated Sarcomas: Final Results of a Phase 2 Clinical Trial
    Location: Room 151
    Presenter: Mateusz SpaÅ‚ek, MD, DSc, PhD, MBA – Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy w Warszawie
  • 2:55 PM - 3:00 PM ET
    1070 - Long-Term Outcomes following Proton-Based Radiation Therapy for Pediatric Chordomas and Chondrosarcomas of the Mobile Spine and the Sacrum
    Location: Room 151
    Presenter: Myrsini Ioakeim-Ioannidou, MD – Massachusets General Hospital
  • 3:00 PM - 3:05 PM ET
    1065 - Use of the 40-Gene Expression Profile (40-GEP) Test to Identify Immune Suppressed Patients with Brigham and Womens Hospital (BWH) T1-T2a Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Meta
    Location: Room 151
    Presenter: Shlomo Koyfman, MD – Cleveland Clinic Foundation
  • 3:05 PM - 3:25 PM ET
    Questions and Answers
    Location: Room 151
  • 3:25 PM - 3:30 PM ET
    Closing
    Location: Room 151
  • 2:30 PM - 2:40 PM ET
    302 - Does Radiation Boost Dose Affect Organ Preservation Rates? A Secondary Analysis of the OPRA Trial
    Location: Room 150
    Presenter: Orly Yariv, MD – National Cancer Inst
  • 2:40 PM - 2:50 PM ET
    304 - Phase II Trial of Organ Preservation Program Using Short-Course Radiation and Folfoxiri for Rectal Cancer (SHORT-FOX): Clinical Response Outcomes
    Location: Room 150
    Presenter: Erqi Pollom, MD, MS – Stanford University
  • 2:50 PM - 3:00 PM ET
    305 - The New Sandwich Total Neoadjuvant Treatment (TNT) Strategy in Locally Advanced Rectal Cancer Patients: First Results of TESS Phase II Trial
    Location: Room 150
    Presenter: WeiWei Xiao, MD, PhD – Sun Yat-Sen University Cancer Center
  • 3:00 PM - 3:10 PM ET
    306 - Radiation Quality Control in the PROSPECT Trial
    Location: Room 150
    Presenter: Harvey Mamon, MD, PhD, FASTRO – Brigham and Women's Hospital/Dana-Farber
  • 3:10 PM - 3:20 PM ET
    307 - Patient Reported Quality of Life and Functional Outcomes after Pre-Operative Short- vs. Long-Course Radiotherapy for Rectal Adenocarcinoma
    Location: Room 150
    Presenter: Syed Shah, MD
  • 3:20 PM - 3:30 PM ET
    Discussant
    Location: Room 150
    Discussant: Emma Holliday, MD – The University of Texas MD Anderson Cancer Center
  • 2:30 PM - 2:40 PM ET
    296 - Induction Chemotherapy plus Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone in High-Risk Locally Advanced Cervical Carcinoma: A Phase 2, Multicenter, Randomized Controlled Trial
    Location: Room 209
    Presenter: Hua Yang, MD – The First Affiliated Hospital of Air Force Medical University
  • 2:40 PM - 2:50 PM ET
    297 - Comparison of Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) vs. Conventional Radiotherapy (4FRT) for Locoregionally Advanced Cervical Cancer on the NRG GY006 Trial
    Location: Room 209
    Presenter: Loren Mell, MD, FASTRO – University of California, San Diego
  • 2:50 PM - 3:00 PM ET
    298 - IMMUNOCERV Phase II Trial Combining the HPV-Specific T Cell Immunotherapy PDS0101 with Chemoradiation for Treatment of Locally Advanced Cervical Cancer
    Location: Room 209
    Presenter: Adam Grippin, MD, PhD – MD Anderson Cancer Center
  • 3:00 PM - 3:10 PM ET
    299 - Influence of Cachexia in Locally Advanced Endometrial Cancer: A Secondary Analysis of NRG GOG 258/RTOG 1203
    Location: Room 209
    Presenter: Eric Donnelly, MD – Northwestern Memorial Hospital
  • 3:10 PM - 3:20 PM ET
    300 - Comparison of Docetaxel and Cisplatin Concurrent and Short-Course Adjuvant Chemotherapy with Cisplatin Concurrent Chemotherapy in Radiotherapy for Locally Advanced Cervical Cancer: A Phase III Multice
    Location: Room 209
    Presenter: Ying Zhang
  • 3:20 PM - 3:30 PM ET
    301 - Five-Year Outcomes of a Phase II Study of Post-Operative Proton Beam Radiation for Gynecologic Cancers
    Location: Room 209
    Presenter: Andrea Russo, MD – Massachusetts General Hospital
  • 3:30 PM - 3:40 PM ET
    Discussant
    Location: Room 209
    Discussant: Kristin Bradley, MD – University of Wisconsin
  • 2:30 PM - 2:40 PM ET
    289 - Requirements and Study Design for the Next Proton Flash Clinical Trials: An International Multidisciplinary Delphi Consensus
    Location: Room 152
    Presenter: Yvonne Klaver, MD, PhD – HollandPTC
  • 2:40 PM - 2:50 PM ET
    290 - First Patient Study with Visual Biofeedback for Gating Delivery Efficiency Improvements on a 1.5 T MR-Linac
    Location: Room 152
    Presenter: Frederique van Gameren, MS – UMC Utrecht
  • 2:50 PM - 3:00 PM ET
    291 - A Sparse Uncollimated ? Counter Network for In Vivo Dose Reconstruction in 225Ac-Based Targeted Alpha Therapy
    Location: Room 152
    Presenter: Rahul Lall, MS, BS – University of California, Berkeley
  • 3:00 PM - 3:10 PM ET
    292 - A Ridge-Filter-Based and Group-Sparsity-Regularized (RFGS) Energy Layer Reduction Method for IMPT
    Location: Room 152
    Presenter: Hao Gao, PhD – University of Kansas Medical Center
  • 3:10 PM - 3:20 PM ET
    293 - Enhancing Proton ARC Treatment Efficiency with a Multi-Arc Approach
    Location: Room 152
    Presenter: Jiangjun Ma, PhD – Shanghai Jiao Tong University
  • 3:10 PM - 3:20 PM ET
    293 - Enhancing Proton ARC Treatment Efficiency with a Multi-Arc Approach
    Presenter: Hao Gao, PhD – University of Kansas Medical Center
  • 3:20 PM - 3:30 PM ET
    294 - AAPM GEC-ESTRO Task Group 342: An Update on Image-Guided Robotic Brachytherapy
    Location: Room 152
    Presenter: Tarun Podder, PhD – SUNY Upstate Medical University
  • 3:30 PM - 3:40 PM ET
    295 - Toward Augmented Reality-Driven MR-Guided Interstitial Brachytherapy
    Location: Room 152
    Presenter: Eric Paulson, PhD – Medical College of Wisconsin
  • 2:30 PM - 2:40 PM ET
    LBA08 - Outcomes and Immune Responses from INNATE: A Randomized Phase II Trial of Sotigalimab Immunotherapy during Neoadjuvant Therapy of Rectal Cancer
    Location: Room 207
    Presenter: Todd Aguilera, MD, PhD – UT Southwestern Medical Center
  • 2:40 PM - 2:50 PM ET
    LBA09 - Neoadjuvant Chemoradiation (CROSS) vs. Perioperative Chemotherapy (FLOT) in Esophageal Adenocarcinoma (EAC): ESOPEC - A Randomized Controlled Prospective Multicenter Phase III Trial
    Location: Room 207
    Presenter: Thomas Brunner, MD – Medical University Graz
  • 2:50 PM - 3:00 PM ET
    LBA10 - Outcomes of RAdium-223 and SABR vs. SABR for oligomEtastatic prostate caNcerS - The RAVENS Phase II Randomized Trial
    Location: Room 207
    Presenter: Ana Kiess, MD, PhD – Johns Hopkins University
  • 3:00 PM - 3:10 PM ET
    LBA11 - A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma
    Location: Room 207
    Presenter: Scott Bratman, MD, PhD – Princess Margaret Hospital
  • 3:10 PM - 3:20 PM ET
    LBA12 - Radiotherapy Target Volume Delineation Based on Post-Induction Chemotherapy Gross Tumor Volume vs. Pre-induction Volume for Locoregionally Advanced Nasopharyngeal Carcinoma: An Open-Label, Non-Inferio
    Location: Room 207
    Presenter: Linglong Tang, MD, PhD – Sun Yat-Sen University Cancer Center
  • 3:20 PM - 3:30 PM ET
    LBA13 - Safety Profile of Durvalumab (D) as Consolidation Treatment (tx) in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) in ADRIATIC: Focus on Pneumonitis and Immune-Mediated Adverse Events (imAEs)
    Location: Room 207
    Presenter: Puneeth Iyengar, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 3:30 PM - 3:40 PM ET
    LBA14 - Neurocognitive Outcome of Conformal Whole Brain Radiotherapy with Bilateral or Unilateral Hippocampal Avoidance Plus Memantine for Brain Metastases: A Phase II Single Blind Randomized Trial
    Location: Room 207
    Presenter: Feng-Ming Hsu, MD, PhD – National Taiwan University Hospital
  • 4:00 PM - 4:10 PM ET
    308 - Phase I/II Prospective Dose Escalation Trial with Proton-Based Radiation Therapy for Chordomas and Chondrosarcomas of the Skull Base and Cervical Spine: Long-Term Results from Proton Radiation Oncolog
    Location: Room 207
    Presenter: Myrsini Ioakeim-Ioannidou, MD – Massachusets General Hospital
  • 4:10 PM - 4:20 PM ET
    309 - Target Volume Delineation for the Re-Irradiation of Recurrent Glioblastoma: MRI- or PET-Based? Results of the GLIAA Prospective Randomized Trial
    Location: Room 207
    Presenter: Anca Grosu, MD – University of Freiburg
  • 4:20 PM - 4:30 PM ET
    310 - Safety and Preliminary Efficacy of AZD1390 + Radiation Therapy for Glioblastoma
    Location: Room 207
    Presenter: Jonathan Yang, MD, PhD – New York University School of Medicine
  • 4:30 PM - 4:40 PM ET
    311 - Cranial Neuropathy Outcomes Following Stereotactic Radiosurgery or Radiotherapy for Skull Base Meningioma
    Location: Room 207
    Presenter: Yazeed Kesbeh, MD – Southern California Permanente Medical Group
  • 4:40 PM - 4:50 PM ET
    Discussant
    Location: Room 207
    Discussant: Tony Wang, MD, FASTRO – Columbia University
  • 4:50 PM - 5:00 PM ET
    1132 - A Multi Institutional Study of the Impact of Reirradiation Dose for Recurrent High Grade Glioma
    Location: Room 207
    Presenter: Corbin Helis, MD
  • 4:00 PM - 4:10 PM ET
    317 - Magnetic Resonance Imaging-Guided vs. Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: 2-Year Outcomes from the MIRAGE Randomized Clinical Trial
    Location: Room 202
    Presenter: Amar Kishan, MD – UCLA Radiation Oncology
  • 4:10 PM - 4:20 PM ET
    318 - Volumetric Changes and Acute Toxicity with 68Ga Prostate-Specific Membrane Antigen vs 18F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
    Location: Room 202
    Presenter: Vishal Dhere, MD – Emory University
  • 4:20 PM - 4:30 PM ET
    319 - Dose Escalated Pelvic Lymph Node Intensity Modulated Radiation Therapy (IMRT) with a Simultaneous Hypofractionated Boost to the Prostate for NCCN Very-High Risk Adenocarcinoma of the Prostate, a Prosp
    Location: Room 202
    Presenter: William Hall, MD – Medical College of Wisconsin (MCW)
  • 4:30 PM - 4:40 PM ET
    320 - Initial Results of a Multi-Institutional Phase 1/2 Trial of Focal Dose-Escalated Salvage High Dose Rate Brachytherapy for Radiorecurrent Prostate Cancer (F-SHARP)
    Location: Room 202
    Presenter: Abhishek Solanki, MD, MS – Loyola University Chicago Stritch School of Medicine
  • 4:40 PM - 4:50 PM ET
    321 - Focal MR-Guided HDR Brachytherapy Boost Combined with SBRT for Localized Prostate Cancer
    Location: Room 202
    Presenter: Carlton Johnny, MD – Princess Margaret Cancer Center, University Health Network
  • 4:50 PM - 5:00 PM ET
    322 - Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase I
    Location: Room 202
    Presenter: Andre Gouveia, MD – McMaster University
  • 4:00 PM - 4:10 PM ET
    312 - Phase II Study of Radiation Volume and Dose De-Intensification Following Tors and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma - Long-Term Results of Expanded Cohort
    Location: Room 145
    Presenter: John Lukens, MD – Hospital of the University of Pennsylvania
  • 4:10 PM - 4:20 PM ET
    313 - Quality of Life (QOL) of Patients with Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) in NRG-HN002
    Location: Room 145
    Presenter: Minh Tam Truong, MD, MBA, MBBS, FASTRO – Boston University School of Medicine
  • 4:20 PM - 4:30 PM ET
    314 - HYHOPE: A Phase I Study of De-Intensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer
    Location: Room 145
    Presenter: Dominic Moon, MD – UT Southwestern Medical Center
  • 4:30 PM - 4:40 PM ET
    315 - HPV-Seq is Prognostic in p16-Positive Oropharyngeal Cancer (OPC): Independent Validation on a Large Prospective Cohort and a Secondary Analysis of NRG-HN002
    Location: Room 145
    Presenter: Eric Stutheit-Zhao, MD, PhD – Princess Margaret Cancer Centre
  • 4:40 PM - 4:50 PM ET
    316 - The Preliminary Analysis of Circulating Human Papillomavirus DNA in a Phase III Trial of Concurrent Chemoradiation (CRT) with Intensity Modulated Proton Therapy (IMPT) vs. IMRT in Oropharyngeal Squamo
    Location: Room 145
    Presenter: Li Wang, MD, PhD – MD Anderson Cancer Center
  • 4:50 PM - 5:00 PM ET
    Discussant
    Location: Room 145
    Discussant: Lachlan McDowell, PhD, MBBS, FRANZCR – Princess Alexandra Hospital
  • 4:00 PM - 4:05 PM ET
    Introduction
    Location: Room 152
  • 4:05 PM - 4:10 PM ET
    1071 - MicroRNA-Based Germline Biomarkers of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Location: Room 152
    Presenter: Joanne Weidhaas, MD, PhD – UCLA Radiation Oncology
  • 4:10 PM - 4:15 PM ET
    1072 - Sequential 90Y Selective Internal Radiation Therapy (SIRT) and Stereotactic Body Radiation Therapy (SBRT) Using 90Y PET-Based Absorbed Dose Maps: Interim Analysis of a Phase I St
    Location: Room 152
    Presenter: Daniel Polan, PhD – University of Michigan
  • 4:15 PM - 4:20 PM ET
    1073 - Comprehensive Geriatric Assessment Guided Radiotherapy in Older Patients with Locally Advanced Rectal Cancer - Results of a Multicenter Prospective Non-Operative Cohort Study
    Location: Room 152
    Presenter: Yuexin Yang, MD – Chinese Academy of Medical Sciences Cancer Hospital Shenzhen Hospital
  • 4:20 PM - 4:25 PM ET
    1074 - Long-Term Outcomes of Definitive Chemoradiation with Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
    Location: Room 152
    Presenter: Grace Lee, MD – Harvard Radiation Oncology Program
  • 4:25 PM - 4:30 PM ET
    1075 - Patient Reported Outcomes after Chemoradiation with IMPT vs. IMRT for Patients with Anal Canal Squamous Cell Carcinoma
    Location: Room 152
    Presenter: Muhammad Shuja, MD – Mayo Clinic Rochester
  • 4:30 PM - 4:55 PM ET
    Questions and Answers
    Location: Room 152
  • 4:55 PM - 5:00 PM ET
    Closing
  • 4:00 PM - 4:05 PM ET
    Questions and Answers
    Location: Room 204
  • 4:05 PM - 4:10 PM ET
    1083 - Outcome and Pattern of Failure Following Definitive High-Dose Radiotherapy for PrImary Vulvar CancEr: Interim Analysis of The DRIVE Multicenter Cohort Study
    Location: Room 204
    Presenter: Anupam Rishi, MD – Moffitt Cancer Center
  • 4:10 PM - 4:15 PM ET
    1084 - A Prospective Single-Arm Study of Daily Online Adaptive Radiotherapy for Cervical Cancer with Reduced PTV Margin: Acute Toxicity Results
    Location: Room 204
    Presenter: Guangyu Wang, MD – Peking Union Medical College Hospital
  • 4:15 PM - 4:20 PM ET
    1085 - Efficacy of Induction Chemotherapy in the Treatment of Locally Advanced Cervical Cancer in Botswana
    Location: Room 204
    Presenter: Emily MacDuffie, MD – University of Pennsylvania
  • 4:20 PM - 4:25 PM ET
    1086 - Outcomes of Radiotherapy in the First-Line Treatment of Recurrent/Metastatic Cervical Cancer: A Multicenter, Retrospective Study
    Location: Room 204
    Presenter: Peng Xie – Shandong Cancer Hospital and Institute
  • 4:25 PM - 4:30 PM ET
    1087 - A Retrospective Comparison of Acute Toxicities in Patients Receiving Pelvic Radiation for Newly Diagnosed Gynecologic Primaries with Intensity Modulated Proton Therapy and Volume Modulated Arc Therapy
    Location: Room 204
    Presenter: Matthew Brown, MD – University of Maryland Radiation Oncology
  • 4:30 PM - 4:35 PM ET
    1088 - The Evaluation of Anxiety and Pain Levels in Patients Receiving Brachytherapy: Turkish Society For Radiation Oncology Brachytherapy Group Study (Brg-001)
    Location: Room 204
    Presenter: Ferah Yildiz, MD – Hacettepe University Medical School
  • 4:35 PM - 4:55 PM ET
    Questions and Answers
    Location: Room 204
  • 4:55 PM - 5:00 PM ET
    Closing
    Location: Room 204
  • 4:00 PM - 4:05 PM ET
    Introduction
    Location: Room 209
  • 4:05 PM - 4:10 PM ET
    1077 - Routine Physics Work Efficacy and Efficiency Improvement with Duty Shared Among Daily Physicist Group for a Multi Hospital Radiation Oncology Network
    Location: Room 209
    Presenter: Eric Paulson, PhD – Medical College of Wisconsin
  • 4:10 PM - 4:20 PM ET
    1078 - Detecting and Classifying On-Treatment Patient Shifts, with In-Vivo EPID Images and Deep Learning
    Location: Room 209
    Presenter: Casey Bojechko, PhD – University of California San Diego
  • 4:15 PM - 4:20 PM ET
    1079 - Automatic Large-Scale Prospective Monitoring and Blind Evaluation of the Performance of Commercial AI Auto-Segmentation in Routine Clinical Practice: Preliminary Results for a Cohort of Breast Cancer
    Location: Room 209
    Presenter: Piotr Dubrowski, MS, MCCPM – Stanford University
  • 4:20 PM - 4:25 PM ET
    1080 - Parallel Prospective Plan of Care Reviews: Evolution over Five Years and Future Directions
    Location: Room 209
    Presenter: Samuel Chao, MD, FASTRO – Cleveland Clinic Taussig Cancer Center
  • 4:25 PM - 4:30 PM ET
    1081 - Systematic Review of Quality Assurance Metrics Used to Standardize Target and Organ at Risk Contours on Cooperative Group Clinical Trials
    Location: Room 209
    Presenter: Leila Tchelebi, MD – Northern Westchester Hospital
  • 4:30 PM - 4:35 PM ET
    1082 - Impact of Standardized Structure Templates on Violations for Radiation Plans Submitted to Co-Operative Group Clinical Trials
    Location: Room 209
    Presenter: Gobind Gill, MD – University of Alabama at Birmingham
  • 4:35 PM - 4:55 PM ET
    Questions and Answers
    Location: Room 209
  • 4:55 PM - 5:00 PM ET
    Closing
    Location: Room 209
  • 5:15 PM - 5:25 PM ET
    328 - Cellular Immune and Genomic Biomarkers in NRG-HN003, a Phase I Study Adding Pembrolizumab to Adjuvant Cisplatin and Radiation Therapy (CRT) in Pathologically High-Risk Head and Neck Cancer (HNSCC)
    Location: Room 146
    Presenter: Julie Bauman, MD – George Washington University Cancer Center
  • 5:25 PM - 5:35 PM ET
    329 - Metrics Derived from Architecture of Tumor-Infiltrating Lymphocytes are Associated with Overall Survival in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Patients: Results from NRG/RTOG 0129 and
    Location: Room 146
    Presenter: German Corredor, PhD, MS – Emory University
  • 5:35 PM - 5:45 PM ET
    330 - Tumor Hypoxia on 18F-Fluoromisonidazole Positive Emission Tomography as a Predictor of Distant Metastasis-Free Survival after Chemoradiation for Head and Neck Squamous Cell Carcinoma: A Pooled Analysi
    Location: Room 146
    Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
  • 5:45 PM - 5:55 PM ET
    331 - Imaging Metrics and HPV ctDNA Kinetics in a Phase II Immuno-Chemoradiation Trial for Locoregionally Advanced p16+ Oropharynx Cancer
    Location: Room 146
    Presenter: Samuel Regan, MD – University of Michigan
  • 5:55 PM - 6:05 PM ET
    332 - Chromosomal Instability as a Prognostic Biomarker for Local Failure in Laryngeal Carcinoma Patients Treated with Definitive Radiation in NRG/RTOG 9512
    Location: Room 146
    Presenter: Pippa Cosper, MD, PhD – University of Wisconsin Madison
  • 6:05 PM - 6:15 PM ET
    Discussant
    Location: Room 146
    Discussant: Zain Husain, MD – Southern California Permanente Medical Group
  • 5:15 PM - 5:25 PM ET
    323 - Inappropriate Denials for Radiation Therapy in Medicare Advantage Plans: An Independent Review Entity and Call for Action
    Location: Room 144
    Presenter: Jared Pasetsky, MD – New York Presbyterian Hospital Columbia Campus
  • 5:25 PM - 5:35 PM ET
    324 - Intrafraction Virtual Reality-Based Environment Modifications Impact on Procedural Anxiety, Heart Rate and External Beam Radiotherapy Experience
    Location: Room 144
    Presenter: Conley Kriegler, MD – University of Alberta
  • 5:35 PM - 5:45 PM ET
    325 - Cost-Effectiveness of Stereotactic Body Radiotherapy vs. Thermal Ablation for Primary Renal Cell Carcinoma: Analysis of the FASTRACK II Trial
    Location: Room 144
    Presenter: Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre
  • 5:45 PM - 5:55 PM ET
    326 - Medical Misinformation about Cancer Recurrence Risks in Patients with Breast Cancer Who Received Radiation
    Location: Room 144
    Presenter: Fumiko Chino, MD – MD Anderson Cancer Center
  • 5:55 PM - 6:05 PM ET
    327 - Prevalence of Control Arm Overperformance as a Contributing Factor to Optimism Bias in Phase 3 Oncology Clinical Trials
    Location: Room 144
    Presenter: Ansel Nalin, MD, PhD – MD Anderson Cancer Center
  • 6:05 PM - 6:15 PM ET
    Discussant
    Location: Room 144
    Discussant: Robin Yabroff, PhD, MBA – American Cancer Society
  • 5:15 PM - 5:20 PM ET
    Introduction
    Location: Room 151
  • 5:20 PM - 5:25 PM ET
    1089 - Genomic Signature for Leptomeningeal Progression in Brain Metastasis Patients Using Liquid Biopsy-Acquired Comprehensive Genomic Profiling
    Location: Room 151
    Presenter: Claire Lanier, MD – Wake Forest School of Medicine
  • 5:25 PM - 5:30 PM ET
    1090 - Cost-Effectiveness of Proton Craniospinal Irradiation (pCSI) in Patients with Solid Tumor Leptomeningeal Metastasis
    Location: Room 151
    Presenter: Anna Dornisch, MD – UC San Diego
  • 5:30 PM - 5:35 PM ET
    1091 - Characterization of Focal Leptomeningeal Disease among Patients with Brain Metastases: A Novel Entity
    Location: Room 151
    Presenter: Nayan Lamba, MD – Harvard Radiation Oncology Program
  • 5:35 PM - 5:40 PM ET
    1092 - Pre-Operative vs. Post-Operative Fractionated Stereotactic Radiotherapy: A Single-Institution Analysis of 534 Resected Metastases
    Location: Room 151
    Presenter: Haley Perlow, MD – Case Western Reserve University/University Hospitals Cleveland Medical Center
  • 5:40 PM - 5:45 PM ET
    1093 - Maximum Tolerated Dose of Neoadjuvant Stereotactic Radiosurgery and Post-Treatment Immune Profiling for Metastatic Brain Tumors: Results of a Phase I Dose Escalation Trial
    Location: Room 151
    Presenter: Samuel Zhang, MD – Cedars-Sinai Medical Center
  • 5:45 PM - 5:50 PM ET
    1094 - Multi-Center Phase I Study of Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases (BM) or Leptomeningeal Metastases (LM) Harboring PI3K Pathway Mutations
    Location: Room 151
    Presenter: Brandon Imber, MD, MS – Memorial Sloan Kettering Cancer Center
  • 5:50 PM - 6:10 PM ET
    Questions and Answers
    Location: Room 151
  • 6:10 PM - 6:15 PM ET
    Closing
    Location: Room 151
  • 5:15 PM - 5:20 PM ET
    Introduction
    Location: Room 152
  • 5:20 PM - 5:25 PM ET
    1101 - Cu-64-Anti-CEA M5A as a Novel Theranostics PET Imaging Agent Pre and Post Neoadjuvant Radiotherapy in Advanced Rectal Cancer
    Location: Room 152
    Presenter: Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center
  • 5:25 PM - 5:30 PM ET
    1102 - Luminal B Single-Cell Signature and Resistance to Hormone Therapy in Breast Cancer
    Location: Room 152
    Presenter: William Chen, MD – UCSF
  • 5:30 PM - 5:35 PM ET
    1103 - Genomic Predictors of Response to Metastasis Directed Therapy with or without Androgen Deprivation Therapy
    Location: Room 152
    Presenter: Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 5:35 PM - 5:40 PM ET
    1104 - Urine Cell-Free DNA Analysis to Detect Tumor Tissue of Origin and Predict Pathologic Complete Response across Genitourinary Malignancies
    Location: Room 152
    Presenter: Pradeep Chauhan, PhD – Mayo Clinic Rochester
  • 5:40 PM - 5:45 PM ET
    1105 - Genomic Characterization of Radiotherapy-Associated Muscle Invasive Bladder Cancer after Prostate Cancer Treatment
    Location: Room 152
    Presenter: N. Ari Wijetunga, MD, PhD, MS – University of North Carolina
  • 5:45 PM - 5:50 PM ET
    1106 - Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes
    Location: Room 152
    Presenter: Kevin Nead, MD, MPhil – MD Anderson Cancer Center
  • 5:50 PM - 6:10 PM ET
    Questions and Answers
    Location: Room 152
  • 6:10 PM - 6:15 PM ET
    Closing
    Location: Room 152
  • 5:15 PM - 5:20 PM ET
    Introduction
    Location: Room 147
  • 5:20 PM - 5:25 PM ET
    1095 - Real-Time Onboard Volumetric Imaging for Tumor Tracking during Treatment and Post-Treatment Dose Verification
    Location: Room 147
    Presenter: Xiaofeng Yang, PhD – Emory University
  • 5:25 PM - 5:30 PM ET
    1096 - Automated Segmentation of Pancreatic Tumor Microvasculature in High-Resolution Optical Coherence Tomography (OCT) Using Pre-Trained Large-Scale Supervised Networks for Early Evaluation of Radiation Th
    Location: Room 147
    Presenter: Elham Abouei, PhD – Emory University
  • 5:30 PM - 5:35 PM ET
    1097 - Ultrafast Short-Arc Diffusion-Based Cone Beam CT Image Reconstruction
    Location: Room 147
    Presenter: Xiang Li, PhD – Memorial Sloan Kettering Cancer Center
  • 5:35 PM - 5:40 PM ET
    1098 - Quantification of Local-Regional Deformation Based on Cherenkov Imaged Vasculature for Breast Radiotherapy Patients
    Location: Room 147
    Presenter: Yao Chen, BS – Dartmouth College
  • 5:40 PM - 5:45 PM ET
    1099 - The Novel Assessment of Stereotactic Body Radiotherapy (SBRT) for Cardiac Radioablation to the Cavotricuspid Isthmus by 13C Pyruvate Metabolic Imaging and Redox Reaction Imaging Using Dynamic Nuclear
    Location: Room 147
    Presenter: Masayuki Matsuo, MD, PhD – Gifu University
  • 5:45 PM - 5:50 PM ET
    1100 - Orthogonal 2D MR Imaging and Manifold Learning Enables Real-Time 3D Tumor Tracking
    Location: Room 147
    Presenter: John Ginn, PhD – Duke University School of Medicine
  • 6:10 PM - 6:15 PM ET
    Closing
    Location: Room 147